Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07632742 · ClinicalTrials.gov registry record · NA
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
A NA study, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT07632742 is a NA study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 180 participants.
The verdict
NCT07632742, a NA study, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Interventions
- DEVICE Magneto 150 holmium laser
- DEVICE Moses 2.0 holmium laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07632742
The ClinicalTrials.gov registry entry for NCT07632742 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magneto 150 holmium laser is the first listed.
NCT07632742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07632742 about?
NCT07632742 is a clinical study titled "Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial". The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
What is the current status of trial NCT07632742?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07632742?
The interventions under investigation include: Magneto 150 holmium laser (DEVICE), Moses 2.0 holmium laser (DEVICE).
Who is sponsoring clinical trial NCT07632742?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.